utilizing insights from compound droplet experiments performed in the microgravity of nasa shuttle mission sts-51-b, dr. taylor wang, has developed an immunoisolation encapsulation system that protects cellular transplants, and sustains cell function — without immunosuppression drugs and their resulting negative side effects. this novel immunoisolation system is a multi-component, multi-membrane capsule that allows independent optimization of all capsule design parameters ensuring reproducible functions in large animals and humans. results of encapsulife's successful large animal trials, have recently been published in peer-reviewed research in transplantation journal. in this landmark research, encapsulated canine pancreatic islets were transplanted into dogs rendered diabetic by total pancreatectomy. no immunosuppression or anti-inflammatory therapy was used. the allotransplantations of encapsulated islets were well tolerated and biocompatible, and normalized fasting blood glucose levels in all of 9 dogs, were achieved for over two hundred days, with a single transplantation. re-transplantation of encapsulated islets — a "booster" — was effective in providing glycemic control beyond the initial 200 days.